Literature DB >> 23063505

Benign lymphoid aggregates in the bone marrow: distribution patterns of B and T lymphocytes.

Kaveh Naemi1, Russell K Brynes, Niloufar Reisian, Abbey Johnston, Ramandeep Dhillon, Vighnesh Walavalkar, Xiaohui Zhao, Sherif A Rezk.   

Abstract

Benign lymphoid aggregates are seen in only a minority of bone marrow specimens, but their distinction from non-Hodgkin lymphoma, particularly B-cell lymphomas, can represent a diagnostic challenge. Although criteria have been proposed to help distinguish between benign and malignant aggregates, a detailed description of the distribution patterns of B and T lymphocytes within benign lymphoid aggregates has not been investigated. One hundred thirty-seven cases of bone marrow specimens containing benign aggregates were studied with a panel of immunostains. A subset of these cases was also examined for immunoglobulin gene rearrangements by polymerase chain reaction. The aggregates were categorized based on size, location (paratrabecular or random), presence of infiltrating edges, and distribution of lymphoid cell populations. In addition, we examined 40 cases of bone marrow biopsies with documented malignant lymphoid aggregates for comparison purposes. We report that the distribution of B and T lymphocytes within lymphoid aggregates may serve as a useful criterion to aid in the separation between benign and malignant aggregates. When aggregates exhibit a predominance of T cells, consist of a central core of T cells surrounded by a rim of B cells, or have a mixed distribution of B and T cells, they are more likely to be benign. On the other hand, an increased likelihood of malignancy occurs when aggregates exhibit a predominance of B cells or consist of a central core of B cells surrounded by a rim of T cells (excluding germinal center formation), and assessing other features worrisome of malignancy (large aggregate size, presence of infiltrative edges, cellular atypia, and paratrabecular location, among others) is warranted.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23063505     DOI: 10.1016/j.humpath.2012.06.012

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  3 in total

1.  The prognostic significance of monoclonal immunoglobulin gene rearrangement in conjunction with histologic B-cell aggregates in the bone marrow of patients with diffuse large B-cell lymphoma.

Authors:  Yoon Ah Cho; Woo Ick Yang; Jae-Woo Song; Yoo Hong Min; Sun Och Yoon
Journal:  Cancer Med       Date:  2016-02-29       Impact factor: 4.452

2.  The immunity features and defects against primary cytomegalovirus infection post-splenectomy indicate an immunocompromised status: A PRISMA-compliant meta-analysis.

Authors:  George Dimitrios Liatsos
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

3.  Constitutive overexpression of TNF in BPSM1 mice causes iBALT and bone marrow nodular lymphocytic hyperplasia.

Authors:  Cyril Seillet; Elysa Carr; Derek Lacey; Michael D Stutz; Marc Pellegrini; Lachlan Whitehead; Joel Rimes; Edwin D Hawkins; Ben Roediger; Gabrielle T Belz; Philippe Bouillet
Journal:  Immunol Cell Biol       Date:  2018-09-08       Impact factor: 5.126

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.